February 06, 2026 a 12:46 pm

STE: Dividend Analysis - STERIS plc

Company Image

STERIS plc presents a reliable dividend profile characterized by consistent payments and moderate growth over recent years. The company has maintained a stable dividend distribution for over two decades, suggesting a strong commitment to returning capital to shareholders. With a current dividend yield of just over 1%, investors might be looking for more substantial income sources, but STERIS's growth trajectory in dividend payouts remains a positive aspect.

Overview πŸ“Š

STERIS plc is situated in the Healthcare sector, offering moderate but consistent dividend payouts.

Metric Value
Sector Healthcare
Dividend yield 1.00%
Current dividend per share 2.23 USD
Dividend history 22 years
Last cut or suspension None

Dividend History πŸ—£οΈ

The historical dividend record of STERIS plc is indicative of its consistent financial performance and firm dedication to shareholder returns, which enhances investor confidence.

Dividend History Chart
Year Dividend per Share (USD)
2026 0.63
2025 2.40
2024 2.18
2023 1.98
2022 1.80

Dividend Growth πŸ“ˆ

The dividend growth metrics demonstrate STERIS’s ability to incrementally enhance its shareholder distribution, providing an indicator of financial health and earning capacity.

Time Growth
3 years 10.06%
5 years 9.28%

The average dividend growth is 9.28% over 5 years. This shows moderate but steady dividend growth.

Dividend Growth Chart

Payout Ratio βœ…

A balanced payout ratio provided by STERIS plc ensures the sustainability of its dividend payments and highlights efficient capital allocation.

Key figure ratio Value
EPS-based 31.88%
Free cash flow-based 22.86%

The moderate EPS payout ratio of 31.88% and the conservative free cash flow payout of 22.86% suggest robust financial health with a margin for reinvestment and growth.

Cashflow & Capital Efficiency πŸ“Š

Examining STERIS's cash flow metrics is integral to understanding its operational efficacy and ability to fund dividends and growth simultaneously through efficient capital management.

Metric 2025 2024 2023
Free Cash Flow Yield 3.48% 2.81% 2.07%
Earnings Yield 2.75% 1.73% 0.56%
CAPEX to Operating Cash Flow 32.24% 37.02% 47.82%
Stock-based Compensation to Revenue 1.05% 1.10% 0.86%
Free Cash Flow / Operating Cash Flow Ratio 67.76% 62.98% 52.18%

The analysis of cashflow dynamics indicates commendable capital efficiency, supporting solid liquidity with room for expanding investments.

Balance Sheet & Leverage Analysis 🧾

The balance sheet metrics shed light on STERIS's leverage and capital structure, ensuring the company remains well-poised to weather economic downturns.

Metric 2025 2024 2023
Debt-to-Equity 0.33 0.54 0.53
Debt-to-Assets 0.22 0.31 0.30
Debt-to-Capital 0.25 0.35 0.35
Net Debt to EBITDA 1.49 2.25 2.26
Current Ratio 1.96 3.08 2.33
Quick Ratio 1.39 2.36 1.63
Financial Leverage 1.54 1.76 1.78

STERIS's controlled leveraging strategy ensures adequate liquidity and minimizes financial risk, reflecting a stable and balanced financial approach.

Fundamental Strength & Profitability πŸš€

Assessing profitability and return metrics affirms STERIS's operational efficiency and capacity to generate profits, which are crucial for sustained growth and investment attraction.

Metric 2025 2024 2023
Return on Equity 9.31% 6.00% 1.76%
Return on Assets 6.06% 3.42% 0.99%
Net Margin 11.26% 7.36% 2.36%
EBIT Margin 16.16% 16.49% 17.44%
EBITDA Margin 24.89% 27.49% 29.63%
Gross Margin 44.01% 43.17% 43.66%
R&D to Revenue 1.97% 2.02% 2.17%

Profitability ratios illustrate a sound corporate governance policy and operational robustness, essential for competitiveness and future expansion.

Price Development πŸ“‰

Price Development Chart

Dividend Scoring System πŸ”

Criterion Score Score Bar
Dividend yield 3
Dividend Stability 5
Dividend growth 4
Payout ratio 5
Financial stability 5
Dividend continuity 5
Cashflow Coverage 4
Balance Sheet Quality 5
Total Score: 36/40

Rating 🌟

STERIS plc's dividend profile is characterized by high stability and gradual growth, making it an appealing pick for long-term investors seeking reliable income. With robust fundamentals and a forward-thinking growth strategy, STERIS holds its ground as a compelling investment within its sector.